Characterizing phosphatidylcholine and sphingomyelin lipids using the ZenoTOF 7600 system
Chen Jinmei, Si Dandan, Long Zhimin and Guo Lihai
SCIEX, China
Lipid analysis using CID fragmentation suffers from the lack of diagnostic fragmentation. Specifically for phosphatidylcholine and sphingomyelin in the positive ion mode, these common isobars are hard to differentiate as the headgroup fragments are the same and without proper deconvolution of the high resolution spectrum these lipid molecular species may be misidentified. Electron activated dissociation (EAD) fragmentation provides unique peaks for each lipid class and allows for deeper characterization of individual lipid molecular species.
Lipids are one class of important nutrients needed by the human body, as they provide a supply of energy, essential fats and building blocks for cells. The chemical structure of a lipid impacts its biological function. Therefore, detailed structural characterization is necessary to determine the molecular mechanisms by which lipids act in basic biology and disease. This characterization is challenging and often requires many different tools to fully determine the structure.1 Mass spectrometry (MS) is often used to analyze lipids, however, this approach typically requires complex and lengthy chromatographic separation to fully separate lipid isomers and multiple experiments to yield interpretable structural information. Moreover, the collision-induced dissociation (CID) approach typically used in MS analysis fails to generate sufficient diagnostic fragments to reliably characterize or identify lipids.
The electron activation dissociation (EAD) technology of the ZenoTOF 7600 system can generate unique fragments that can be used to properly identify lipid compounds.2 This fragmentation mode can provide additional diagnostic fragments to determine lipid class, backbone type and regioisomerism. At the same time, EAD can break acyl chains at each carbon along the fatty acid to determine carbon length and double bond(s) position. Here, EAD using high kinetic energy was used to provide in-depth characterization of different lipid compounds.3,4
Sample preparation: Avanti SPLASH Lipidomix standards were diluted in mobile phase B (Table 1) and data was acquired on this neat standard injection. Rat plasma was extracted by mixing with isopropyl alcohol in a 1:3 ratio, vortexing and then centrifuging. Supernatant was removed then diluted in mobile phase B for analysis.
Chromatography: An ExionLC system with a Phenomenex Kinetex column (C18, 2.6 µm, 100x3.0 mm; P/N 00F-4462-Y0) was used to perform the separation. The total run time was 20 min. A 2.0 µL injection was used. Column temperature was held at 50°C. Table 1 shows the chromatographic gradient used.
Mass spectrometry: Samples were analyzed on the ZenoTOF 7600 system using information dependent acquisition (IDA) in the positive ion mode. Table 2 lists the conditions for analysis, including EAD parameters.
CID is the most widely used dissociation when studying lipids such as phosphatidylcholine (PC). However, for proper identification, this lipid class is often analyzed in both positive and negative ion mode. The positive ion mode provides information about the headgroup, while the negative ion mode provides information about the fatty acid chains. This joint verification can confirm the class and fatty acid composition of the lipid, but that is the limit of information from CID MS/MS.
EAD fragmentation generates more informative fragment ions and therefore enables a deeper characterization of the compound. As a result, it is possible to discern the position of the fatty acid chains and the double bond position Figure 1 shows a standard for PC(15:0/18:1(d7)∆9). The headgroup is characterized by the canonical loss of m/z 184.0802 and the glycerol backbone is identified by 2 fragments at m/z 224.1065 and 226.0858. The diagnostic ion m/z 498.3837 determines that the sn-2 fatty acid chain is FFA18:1(d7). The fragmentation efficiencies along the acyl chain are low, especially around the double bond (Figure 1, bottom). However the MS/MS sensitivity afforded by the Zeno trap enables interrogation. The position where the double bond appears is the difference in m/z of 12 (C=C) rather than 14 (CH2 loss) and the ladder of peaks are highlighted with red arrows. Figure 1 therefore indicates that a double bond is present at C9 position.
For characterization of a lipid in matrix, rat plasma was extracted and evaluated. Figure 2 (left panel) shows the EAD MS/MS spectrum for a lipid detected in plasma with a precursor ion at m/z 758.5675. This compound was identified as a PC based on the fragments detected at m/z 184.0816, m/z 224.1067 and m/z 226.0860.5 However without further information, this lipid would need to be reported as PC(34:2), with multiple combinations for fatty acid chain lengths, their localization, and degrees of desaturation occurring at one or both fatty acids, ie. PC(18:1_16:1), PC(16 :1_18:1), PC(18:2_16:0), PC(18:0_16:2), etc. Detecting the diagnostic ion m/z 489.3263 confirms the localization of fatty acid 18:2 at the sn-2 position, which therefore identifies the lipid as PC(16:0/18:2).
A magnified view of the acyl chain fragmentation is shown in the right panel of Figure 2. Calculating the difference between the fragments reveals that double bonds are present at the C6 and C9 positions. This information completes the characterization of this lipid compound as PC(16:0/18:2 (∆6,9)).
When using CID fragmentation, the head group fragments of sphingomyelin and phosphatidylcholine are the same. It can be seen in Figure 3 that both types of lipids will provide a characteristic choline headgroup fragment of m/z 184.0769 and m/z 184.0739, and it is impossible to directly confirm which lipid these fragments belong. Often, researchers will infer SM and PC identity based on odd and even precursor m/z values, respectively. However, this approach is unreliable due to isobaric overlap and can result in errors. For example, a PC can be falsely identified or sometimes overreported, as it will appear as the C13 isotope of SM if proper deconvolution is not performed.
The use of EAD fragmentation generates distinctive fragments that allow lipid species to be properly identified. The sphingosine backbone of SM produces 2 peaks at m/z 225.1015 and m/z 253.1081.6 This is pattern is unique to SM and unlike the C-O doublet that characterizes the glycerol backbone of PC (Figure 1). Figure 4 illustrates the full characterization of the SM(d18:1/18:1(d9)) standard. The left panel shows the full spectrum for the SM standard, including fragments indicative of the amide-linked backbone, specifically sphingosine, along with the localization fragments for the sn-1 and sn-2 chains. Magnified on the right panel indicates the presence of a double bond at the C9 position on the sn-2 chain.
To evaluate capabilities of characterization of an endogenous SM extracted plasma was analyzed. The lipid shown in Figure 5 can be identified as a SM by the fragments at m/z 184.0838, m/z 225.1015 and m/z 253.1075, but this lipid could be SM(d16:0_18:1), SM(d16:1_18:0), SM(d18:0_16:1), SM(d18:1_16:0), etc. The diagnostic ions produced at m/z 447.3151 and m/z 463.3363, shown in the left panel of Figure 5, reveal that the sphingosine chain is d18:1 and the sn-2 fatty acid chain is 16:0. Calculating the m/z difference between the fragments in the right panel confirmed that the sn-2 fatty acid chain does not have any double bonds. The lipid compound detected in plasma was therefore identified as SM(d18:1/16:0).
The use of electron activated dissociation (EAD) fragmentation on the ZenoTOF 7600 system generates rich lipid structural information, which enables complete structural identification. The fragmentation spectra generated with EAD enabled the differentiation of PC and SM lipid standards compared to conventional CID. The Zeno MS/MS functionality provides significant MS/MS sensitivity gains that enables localization of the double bond(s). This approach successfully generated data that were used to identify phosphatidylcholine (PC) and sphingomyelin (SM) lipids in complex plasma samples.